VEEV NYSE · Software for drug makers

Veeva Systems

Filings read on 20 November 2026

Revenue 2016: $551m2025: $3.2bn

Fit to the checklist
80.0 of 100

Counted on the 11 of 15 questions that could be answered from the filings. A second reader, working blind from the same quotes, arrived at 81.8 with 11 answered.

did not qualify: the bar is 9011 of 15 answered

A study note on how the company fits a fixed list of questions. Not a view on the shares, not a recommendation. How the marks are made

Position heldThe author holds no shares in this company. Stated on 21 November 2026.

01Quiet leadership

100 of 100 2 of 3 answered
Question 1.1

The chief executive credits others and owns the misses

Could not assess

The last two letters to shareholders and what the chief executive says alongside results.

How all 12 companies answered this

Quotes in press releases credit 'the Veeva team' and customers. But there are no letters to shareholders and no earnings calls, and no quote in which the chief executive owns a miss with a cause.

Found in the filings, but not enough to settle a mark:

Thanks to the Veeva team for your outstanding work and to our customers for your partnership.

Thanks to the team’s focus on customer success and product excellence, our impact and strategic partnership with the industry is increasing.

Question 1.2

The chief executive grew up inside the company

5 of 5

The biography in the proxy statement.

How all 12 companies answered this

The proxy statement lists '2007 to present: Co-founder and CEO, Veeva Systems Inc.', and the annual report calls Peter P. Gassner 'our founder and Chief Executive Officer'.

For example, our founder and Chief Executive Officer, Peter P. Gassner, is critical to our vision, strategic direction, culture, products, and technology.

Question 1.3

No restructuring theatre

5 of 5

Restructuring programmes, company-wide rebrands and strategy overhauls in ten years of annual reports.

How all 12 companies answered this

Across ten annual reports, restructuring is mentioned only in standard wording about the risks of acquisitions ('may also result in ... restructuring charges'). They show no announced program, rebrand or strategy overhaul.

Acquisitions may also result in purchase accounting adjustments, write-offs or restructuring charges, which may negatively affect our results.

02People before plans

70 of 100 2 of 3 answered
Question 2.1

A real system for developing people

3 of 5

The people section of the annual report and the proxy statement.

How all 12 companies answered this

The proxy statement names the Generation Veeva graduate program and says the company grew 'without the need for layoffs'. It gives no numbers.

Through our measured and thoughtful hiring process, we have continued to grow steadily without the need for layoffs.

Question 2.2

Executives stay

4 of 5

Filings that report officer departures over the last three years.

How all 12 companies answered this

Two named executive officers from the 2026 proxy statement left in the period: Schwenger resigned (filing of 2026-08-20) and Faddis is retiring (filing of 2026-04-20). Diamond, Cabral and Bowman are not named executive officers in that proxy statement.

Josh Faddis intends to retire from his role as Senior Vice President, General Counsel, effective as of November 1, 2026.

On November 17, 2025, Kristine Diamond, Chief Accounting Officer, informed Veeva Systems Inc. (“Veeva”) of her decision to resign from her position effective as of December 11, 2025.

Question 2.3

The best people on the biggest opportunities

Could not assess

Who runs the main growth area, and where they came from.

How all 12 companies answered this

The filings read show no named senior leader moved to run the main growth area, and no revolving door either.

No checked quote is on file for this question. The company's filings at sec.gov

03Narrow focus

73 of 100 3 of 3 answered
Question 3.1

Best in the world at something

4 of 5

Market position claims and the sources given for them.

How all 12 companies answered this

The annual report says 'Veeva is the leading provider of industry cloud solutions for the global life sciences industry'. That is the company's own claim, with no independent market share figure.

Veeva is the leading provider of industry cloud solutions for the global life sciences industry.

Our CRM solutions primarily compete with Salesforce, Inc., which has developed a life sciences industry-specific CRM application.

Question 3.2

The same business for a decade

4 of 5

The business description from ten years ago beside the latest one.

How all 12 companies answered this

The 2016 and 2026 business descriptions both cover industry cloud software and data for life sciences. The 2026 annual report adds a separate offering, Veeva Business Consulting, which is a modest step into a neighbouring area.

Veeva is a leading provider of industry cloud software and data solutions for the global life sciences industry.

In addition to cloud-based solutions that meet the specific needs of our life sciences customers, we also offer professional services to help customers maximize the value they get from those solutions.

Question 3.3

A clear way of making money per unit

3 of 5

Whether management reports profit or revenue per customer, store, shipment or similar.

How all 12 companies answered this

Management reports customer counts (1,552, 1,477, 1,432). It reports no revenue or profit measure per customer. That can only be worked out from the filings.

As of January 31, 2026, 2025, and 2024, we served 1,552, 1,477, and 1,432 customers, respectively.

Veeva finished the year with 1,388 customers, up 174 from the year prior.

04Discipline and straight talk

80 of 100 2 of 3 answered
Question 4.1

Careful with capital

3 of 5

Arithmetic on ten years of figures reported to the SEC: the change in share count and debt against free cash flow.

How all 12 companies answered this

Arithmetic from SEC figures gives 3. The only acquisition with a stated cost, Ostro at about $100 million, is far below a fifth of the company's value.

+13.2%
Shares outstanding, 2016 to 2025148m to 167m

Ten years of figures the company reported to the SEC. Its annual reports at sec.gov

Question 4.2

Faces bad news squarely

Could not assess

The worst quarter or year of the last five, and what management said next.

How all 12 companies answered this

Operating income fell 9% in fiscal 2023 and the release names no cause. The filings read hold no earnings calls to show what management said next.

Found in the filings, but not enough to settle a mark:

Fiscal year 2023 operating income was $459.1 million, compared to $505.5 million one year ago, a decrease of 9% year over year.

Fourth quarter operating income was $108.9 million, compared to $119.7 million one year ago, a decrease of 9% year over year.

Question 4.3

Earnings backed by cash

5 of 5

Arithmetic: five years of free cash flow against reported profit, and whether results were ever restated.

How all 12 companies answered this

Over five years, free cash flow was 1.62 times net income, which gives a 5. The SEC filing list shows no restatement filing in the last ten years.

2016: $137mFree cash flow2025: $1.4bn

Ten years of figures the company reported to the SEC. Its annual reports at sec.gov

05Steady compounding

80 of 100 2 of 3 answered
Question 5.1

Steady growth, year after year

5 of 5

Arithmetic: years of falling revenue out of the last ten.

How all 12 companies answered this

Revenue did not fall in any of the last ten years, which gives a 5.

2016: $551mRevenue2025: $3.2bn

Ten years of figures the company reported to the SEC. Its annual reports at sec.gov

Question 5.2

No pivots or short-lived programmes

Could not assess

Strategy statements across ten years of annual reports.

How all 12 companies answered this

Veeva Network products named in the 2016 annual report are absent from the 2026 one. The filings read cannot show whether they were abandoned, renamed or folded into something else.

Found in the filings, but not enough to settle a mark:

Veeva Network Customer Master, our cloud-based customer master data management solution, is designed to help life sciences companies create and maintain complete and accurate master records for individual healthcare professionals and healthcare organizations.

Veeva Network Product Master, planned for general release in 2016, is our cloud-based product master data management offering to help life sciences companies create complete and accurate product master records.

Question 5.3

A widening lead

3 of 5

Arithmetic: operating margin in the last three years against the three before.

How all 12 companies answered this

The arithmetic from SEC figures gives a 3. The filings read hold only customer counts and the share of revenue from the top 10 customers. There is no customer retention or market share data that would justify changing it.

2016: 21.9%Operating margin2025: 28.7%

Ten years of figures the company reported to the SEC. Its annual reports at sec.gov

As of January 31, 2026, 2025, and 2024, we served 1,552, 1,477, and 1,432 customers, respectively.

In each of our fiscal years ended January 31, 2026, 2025, and 2024, our top 10 customers accounted for 28% of our total revenues.

One study
a month

A new company, every answer with its source. No tips, no alerts, no hurry.